Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence.
about
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementQuality of meta-analysis in nursing fields: An exploration based on the JBI guidelinesEvaluation and initial management of acute kidney injury.A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysisMechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocol.Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinicThe kidney in the critically ill.Medical therapy of acute kidney injury.Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathyEfficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials.TACE versus TAE as therapy for hepatocellular carcinoma.Hospital-acquired acute kidney injury.Nephrotoxicity of contrast media and protective effects of acetylcysteine.Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.Quality of meta-analyses in major leading gastroenterology and hepatology journals: A systematic review.Efficacy of N-Acetylcysteine in Preventing Acute Kidney Injury After Cardiac Surgery: A Meta-Analysis Study.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.Risk of contrast induced nephropathy in diabetic patients affected by critical limb ischemia and diabetic foot ulcers treated by percutaneous transluminal angioplasty of lower limbs.Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine?Using Principles of Behavioral Economics to Mitigate Drug ShortagesN-acetylcysteine for antioxidant therapy: pharmacology and clinical utility
P2860
Q21092360-CC4852F7-7E1A-4E55-83C0-C3CA872C9182Q21562278-DDEF2BA6-3A5A-4D4D-AB31-C7D28F6F74E2Q27860581-F2328C31-8659-45AB-B81D-4186084DF3ADQ27860868-E43076B1-F2B8-4A3A-9FDD-91D2C52FE85FQ30376607-F64C0F7E-75DD-41C6-91EB-2C732597F21FQ30439287-B2CBC97B-8C59-48B8-AC31-06A0D734681DQ33305487-6A08F2D3-E704-46A2-8320-1B91483427CDQ33497692-00F23088-CC05-451F-B8BB-39F0A41D8C71Q34150613-B451F47E-34CF-4668-BF06-6EB118B7608DQ35930002-7BDB0DE0-22FB-4B26-B346-6AA22C13A753Q36666993-0B0D2EAD-957E-4495-A97A-00220A810D48Q36938144-9CD75066-72A7-456E-9918-571584C9FE3AQ37088297-C7AB890E-F400-4963-BA53-FFA5EE43F536Q37251655-1C7070EF-6F53-4CA5-B020-556BF188534CQ37285952-B318BBFF-303C-4122-AB61-6831623D2A71Q37300023-DFB47939-4706-40DD-A2CB-C902140C18B7Q37793783-0ED14C6B-9925-43AB-9E13-2471B47018EAQ37817813-5E27572D-2C87-4AC9-AD64-CCBA3937467FQ37922124-C8FED747-43B6-4594-9EEA-2CC5F5D43299Q38947612-54C627E4-89C4-4549-BD2A-16E55EBEF398Q39070490-F5FA9D62-65A1-4734-8972-8EB57FA3BA7CQ42035537-7FB8B8FB-6D77-493B-96DE-2617E3C39015Q48954684-ACDA6824-8A1D-40EA-93F6-7A0B6A694254Q51542121-92E1DE4D-57B4-40A1-807E-D3417D512860Q54984333-8040D3D7-9A07-4475-9CDF-89C8DDAE251DQ55887376-D8369A8C-83E8-4CCA-8BCC-F7756FEE5819
P2860
Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Acetylcysteine in the preventi ...... in the evolution of evidence.
@ast
Acetylcysteine in the preventi ...... in the evolution of evidence.
@en
type
label
Acetylcysteine in the preventi ...... in the evolution of evidence.
@ast
Acetylcysteine in the preventi ...... in the evolution of evidence.
@en
prefLabel
Acetylcysteine in the preventi ...... in the evolution of evidence.
@ast
Acetylcysteine in the preventi ...... in the evolution of evidence.
@en
P2093
P1476
Acetylcysteine in the preventi ...... in the evolution of evidence.
@en
P2093
Braden J Manns
Finlay A McAlister
Sean M Bagshaw
William A Ghali
P304
P356
10.1001/ARCHINTE.166.2.161
P407
P577
2006-01-01T00:00:00Z